Friedreich’s ataxia (FA) is a progressive genetic disorder of the nervous system that is characterized by incoordination and cardiac degeneration. It results from the expression of a non-functional frataxin protein, which normally helps to maintain appropriate iron levels within mitochondria. The mutant protein causes cytosolic iron deficiency and mitochondrial iron overloading by methods that are not understood. Huang et al. used a conditional knockout mouse model, where frataxin was specifically deleted in only the heart and skeletal muscle, to investigate the role of frataxin in iron localization and metabolism in these tissues. Without frataxin, the expression of the iron import protein transferrin receptor 1 (TfR1) increases along with heme catabolism by heme oxygenase 1. Iron storage in cytosolic ferritin decreases and the accumulating free iron is transported into mitochondria through the transport protein mitoferrin 2 (Mfrn2), which is also upregulated in the absence of frataxin. This demonstrates a possible mechanism for the mitochondrial iron loading that underlies the pathology of Friedreich’s ataxia.
Neurodegeneration: ironing out the mechanism of Friedreich’s ataxia
Neurodegeneration: ironing out the mechanism of Friedreich’s ataxia. Dis Model Mech 5 November 2009; 2 (11-12): 518. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Registration is now open for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, we will present the very latest advances in modelling human genetic disease.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that aim to move heart failure to heart success by fundamentally addressing the roots of failure to identify curative strategies.
Crossroads in Virology

Our October Editorial written by Sumana Sanyal emphasises the urgency of a concerted effort in understanding virus–host interactions to inform the development of therapeutics and vaccines, helping to predict disease outcomes. Read the full Editorial here.
A Model for Life - an interview with Professor Kiran Musunuru




Read our new A Model for Life interview with Kiran Musunuru. Prof Musunuru investigates the mechanisms of disease in model systems, with the ultimate goal of developing innovative gene editing therapies.
Sustainable Conferencing Initiative

Through our Sustainable Conferencing Grants, we promote the use of new technology and greener modes of travel. Our blog posts showcase examples of sustainability in action and share experience about how new technologies and conference formats work in practice.
Other journals from
The Company of Biologists